Matt Biegler

Stock Analyst at Oppenheimer

(n/a)
# 4,468
Out of 4,789 analysts
2
Total ratings
n/a
Success rate
-41.08%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matt Biegler

OnKure Therapeutics
Mar 11, 2025
Maintains: Outperform
Price Target: $35$30
Current: $4.30
Upside: +597.67%